Nanobiotix Files 6-K Report with Press Release
Ticker: NBTX · Form: 6-K · Filed: Mar 30, 2026 · CIK: 0001760854
| Field | Detail |
|---|---|
| Company | Nanobiotix S.A. (NBTX) |
| Form Type | 6-K |
| Filed Date | Mar 30, 2026 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, press-release
TL;DR
Nanobiotix dropped a 6-K with a presser on 3/30/26 - check for news.
AI Summary
Nanobiotix S.A. filed a Form 6-K on March 30, 2026, reporting its activities as a foreign issuer. The filing includes a press release as Exhibit 99.1, detailing the company's operations and potentially significant updates. The company's mailing and business address is 60 Rue de Wattignies, Paris, France.
Why It Matters
This filing provides an update on Nanobiotix's corporate activities and may contain material information relevant to investors regarding its business and financial status.
Risk Assessment
Risk Level: medium — Form 6-K filings often contain material updates that can significantly impact a company's stock price, requiring careful investor attention.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer of the 6-K report
- 0001760854 (company) — CIK number for Nanobiotix S.A.
- 2026-03-30 (date) — Filing date and period of report
- 60 RUE DE WATTIGNIES PARIS I0 75012 (location) — Mailing and business address of Nanobiotix S.A.
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer required by the SEC, used to provide information that the company has made or is required to make public in its home country, or that it has distributed or made available to its security holders.
What document is included as Exhibit 99.1 in this filing?
Exhibit 99.1 is a press release.
What is Nanobiotix S.A.'s CIK number?
Nanobiotix S.A.'s CIK number is 0001760854.
Where is Nanobiotix S.A. located?
Nanobiotix S.A.'s mailing and business address is 60 Rue de Wattignies, Paris, France.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on March 30, 2026.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 8.5 · Accepted 2026-03-30 06:00:09
Filing Documents
- f6k_032826.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 11KB
- 0001171843-26-001999.txt ( ) — 17KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Nanobiotix S.A. (Registrant) Date: March 30, 2026 /s/ Bart Van Rhijn Bart Van Rhijn Chief Financial Officer